SUZHOU, China – Navigating the obstacle course of China's regulatory system requires strategic thinking, long-term planning, creative problem solving and it doesn't hurt to have deep pockets, according to the experts discussing cross-border approvals at the Chinabio Partnering conference.

India is considering waiving a global patent for cancer drug dasatanib under provisions of the country's Patent Act that allow it to make the move for public noncommercial use.

SUZHOU, China ­– "Innovation" is a prominent theme in China's life sciences community, but for all the talk about the need to move from generics to novel drugs, focusing on the science without generating results is a wasted effort. That, in short, is a key message emerging from Chinese life science executives and research leaders at the Chinabio Partnering Forum.

Gloria Pharmaceuticals Co., of Beijing, and Cumberland Pharmaceuticals Inc., of Nashville, Tenn., formed a joint R&D initiative. Each company has made a $1 million investment in Cumberland Emerging Technologies (CET), which is majority-owned by Cumberland and partnered with academic research centers to develop promising biopharmaceutical technologies.

Lupin Ltd., of Mumbai, India, appointed Theresa Stevens chief corporate development officer for its global operations.

SUZHOU, China – On the eve of a key biopharmaceutical partnering fest – the Chinabio Partnering Forum begins here today – BioWorld Asia took a closer look at what it takes for successful dealmaking in the most populous nation on earth. The experts all agree: the landscape for licensing in China is getting more crowded with competitors.

Preferring engagement to extreme censure, the U.S. Trade Representative (USTR) hopes to work with officials in China and India this year to create a more even playing field for U.S. medical products in those markets.

HONG KONG ­– International researchers led by the Shanghai Institute of Materia Medica (SIMM) at the Chinese Academy of Sciences have mapped the detailed structure of a receptor with a key role in platelet activation and blood clotting, which has important implications for development of new treatments for cardiovascular and possibly other diseases.

SUZHOU, China – With the 6th Chinabio Partnering Forum happening this week – designed to foster cross-border partnering – the event is considered the best place for the world to meet up-and-coming Chinese life science companies. Several trends driving partnering this year promise to make the event the liveliest yet.